[On the pharmacology of the alkaloid ervamidine (acquamidine)].
D000470:Alkaloids / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000633:toxicity; D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents; D002415:Cats; D004357:Drug Synergism; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005730:Ganglionic Blockers / Q000494:pharmacology; D006591:Hexobarbital / Q000494:pharmacology; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D051379:Mice; D009132:Muscles / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology
D000470:Alkaloids; D000959:Antihypertensive Agents; D005730:Ganglionic Blockers; D006993:Hypnotics and Sedatives; D013565:Sympatholytics; D006591:Hexobarbital; D000661:Amphetamine; D004837:Epinephrine
K farmakologii alkaloida érvamidina (akkuamidina)